Literature DB >> 27633574

Comparison of human lung cancer cell radiosensitivity after irradiations with therapeutic protons and carbon ions.

Otilija D Keta1, Danijela V Todorović2, Tanja M Bulat1, Pablo Ga Cirrone3, Francesco Romano3, Giacomo Cuttone3, Ivan M Petrović1, Aleksandra M Ristić Fira1.   

Abstract

The aim of this study was to investigate effects of irradiations with the therapeutic proton and carbon ion beams in two non-small cell lung cancers, CRL5876 adenocarcinoma and HTB177 large cell lung carcinoma. The DNA damage response dynamics, cell cycle regulation, and cell death pathway activation were followed. Viability of both cell lines was lower after carbon ions compared to the therapeutic proton irradiations. HTB177 cells showed higher recovery than CRL5876 cells seven days following the treatments, but the survival rates of both cell lines were lower after exposure to carbon ions with respect to therapeutic protons. When analyzing cell cycle distribution of both CRL5876 and HTB177 cells, it was noticed that therapeutic protons predominantly induced G1 arrest, while the cells after carbon ions were arrested in G2/M phase. The results illustrated that differences in the levels of phosphorylated H2AX, a double-strand break marker, exist after therapeutic proton and carbon ion irradiations. We also observed dose- and time-dependent increase in the p53 and p21 levels after applied irradiations. Carbon ions caused larger increase in the quantity of p53 and p21 compared to therapeutic protons. These results suggested that various repair mechanisms were induced in the treated cells. Considering the fact that we have not observed any distinct change in the Bax/Bcl-2 ratio following irradiations, it seemed that different types of cell death were involved in the response to the two types of irradiations that were applied.

Entities:  

Keywords:  DNA damage; Lung cancer; carbon ions; cell irradiation; protons; radiobiology

Mesh:

Substances:

Year:  2016        PMID: 27633574      PMCID: PMC5444635          DOI: 10.1177/1535370216669611

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  54 in total

Review 1.  Cell-cycle checkpoints and cancer.

Authors:  Michael B Kastan; Jiri Bartek
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

2.  Response of a radioresistant human melanoma cell line along the proton spread-out Bragg peak.

Authors:  Ivan Petrović; Aleksandra Ristić-Fira; Danijela Todorović; Lela Korićanac; Lucia Valastro; Pablo Cirrone; Giacomo Cuttone
Journal:  Int J Radiat Biol       Date:  2010-09       Impact factor: 2.694

Review 3.  p21 stability: linking chaperones to a cell cycle checkpoint.

Authors:  Geng Liu; Guillermina Lozano
Journal:  Cancer Cell       Date:  2005-02       Impact factor: 31.743

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 5.  Cancer treatment and survivorship statistics, 2012.

Authors:  Rebecca Siegel; Carol DeSantis; Katherine Virgo; Kevin Stein; Angela Mariotto; Tenbroeck Smith; Dexter Cooper; Ted Gansler; Catherine Lerro; Stacey Fedewa; Chunchieh Lin; Corinne Leach; Rachel Spillers Cannady; Hyunsoon Cho; Steve Scoppa; Mark Hachey; Rebecca Kirch; Ahmedin Jemal; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2012-06-14       Impact factor: 508.702

Review 6.  Initial events in the cellular effects of ionizing radiations: clustered damage in DNA.

Authors:  D T Goodhead
Journal:  Int J Radiat Biol       Date:  1994-01       Impact factor: 2.694

7.  New colorimetric cytotoxicity assay for anticancer-drug screening.

Authors:  P Skehan; R Storeng; D Scudiero; A Monks; J McMahon; D Vistica; J T Warren; H Bokesch; S Kenney; M R Boyd
Journal:  J Natl Cancer Inst       Date:  1990-07-04       Impact factor: 13.506

Review 8.  ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks.

Authors:  M F Lavin
Journal:  Oncogene       Date:  2007-12-10       Impact factor: 9.867

Review 9.  Molecular Pathways: Overcoming Radiation Resistance by Targeting DNA Damage Response Pathways.

Authors:  Meredith A Morgan; Theodore S Lawrence
Journal:  Clin Cancer Res       Date:  2015-07-01       Impact factor: 13.801

10.  Regulation of senescence in cancer and aging.

Authors:  Yahui Kong; Hang Cui; Charusheila Ramkumar; Hong Zhang
Journal:  J Aging Res       Date:  2011-03-08
View more
  5 in total

1.  Gene expression profiling of breast cancer cell lines treated with proton and electron radiations.

Authors:  Valentina Bravatà; Luigi Minafra; Francesco Paolo Cammarata; Pietro Pisciotta; Debora Lamia; Valentina Marchese; Giada Petringa; Lorenzo Manti; Giuseppe Ap Cirrone; Maria Carla Gilardi; Giacomo Cuttone; Giusi Irma Forte; Giorgio Russo
Journal:  Br J Radiol       Date:  2018-07-05       Impact factor: 3.039

Review 2.  The Radiobiological Effects of Proton Beam Therapy: Impact on DNA Damage and Repair.

Authors:  Eirini Terpsi Vitti; Jason L Parsons
Journal:  Cancers (Basel)       Date:  2019-07-05       Impact factor: 6.639

Review 3.  Clinical Progress in Proton Radiotherapy: Biological Unknowns.

Authors:  Laura Vanderwaeren; Rüveyda Dok; Kevin Verstrepen; Sandra Nuyts
Journal:  Cancers (Basel)       Date:  2021-02-03       Impact factor: 6.639

4.  Cellular and Molecular Biological Alterations after Photon, Proton, and Carbon Ions Irradiation in Human Chondrosarcoma Cells Linked with High-Quality Physics Data.

Authors:  Birgit Lohberger; Sandra Barna; Dietmar Glänzer; Nicole Eck; Sylvia Kerschbaum-Gruber; Katharina Stasny; Andreas Leithner; Dietmar Georg
Journal:  Int J Mol Sci       Date:  2022-09-28       Impact factor: 6.208

5.  Preliminary study on radiosensitivity to carbon ions in human breast cancer.

Authors:  Qiuning Zhang; Yarong Kong; Zhen Yang; Yang Liu; Ruifeng Liu; Yichao Geng; Hongtao Luo; Hong Zhang; Hongyan Li; Shuangwu Feng; Xiaohu Wang
Journal:  J Radiat Res       Date:  2020-05-22       Impact factor: 2.724

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.